NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · IEX Real-Time Price · USD
21.44
-0.36 (-1.65%)
At close: Apr 25, 2024, 4:00 PM
20.91
-0.53 (-2.47%)
After-hours: Apr 25, 2024, 6:57 PM EDT

NAMS Statistics

Total Valuation

NAMS has a market cap or net worth of $1.91 billion. The enterprise value is $1.55 billion.

Market Cap 1.91B
Enterprise Value 1.55B

Important Dates

The last earnings date was Friday, March 31, 2023.

Earnings Date Mar 31, 2023
Ex-Dividend Date n/a

Share Statistics

NAMS has 89.27 million shares outstanding.

Shares Outstanding 89.27M
Owned by Insiders (%) 5.77%
Owned by Institutions (%) 76.00%
Float 29.58M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 122.25
Forward PS 176.28
PB Ratio 6.19
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 98.93
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.00.

Current Ratio 6.95
Quick Ratio 6.95
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -49.30% and return on invested capital (ROIC) is -63.43%.

Return on Equity (ROE) -49.30%
Return on Assets (ROA) -42.90%
Return on Capital (ROIC) -63.43%
Revenue Per Employee $539,847
Profits Per Employee -$6.78M
Employee Count 29
Asset Turnover 0.03
Inventory Turnover n/a

Taxes

In the past 12 months, NAMS has paid $28,952 in taxes.

Income Tax 28,952
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +51.73% in the last 52 weeks. The beta is 0.02, so NAMS's price volatility has been lower than the market average.

Beta (1Y) 0.02
52-Week Price Change +51.73%
50-Day Moving Average 21.49
200-Day Moving Average 14.07
Relative Strength Index (RSI) 54.39
Average Volume (30 Days) 236,877

Short Selling Information

Short Interest 335,210
Short Previous Month 337,884
Short % of Shares Out 0.76%
Short % of Float n/a
Short Ratio (days to cover) 1.98

Income Statement

In the last 12 months, NAMS had revenue of $15.66 million and -$196.60 million in losses. Loss per share was -$2.31.

Revenue 15.66M
Gross Profit 15.11M
Operating Income -196.19M
Pretax Income -189.70M
Net Income -196.60M
EBITDA -189.65M
EBIT -189.70M
Loss Per Share -$2.31
Full Income Statement

Balance Sheet

The company has $365.06 million in cash and $64,338 in debt, giving a net cash position of $365.00 million or $4.09 per share.

Cash & Cash Equivalents 365.06M
Total Debt 64,338
Net Cash 365.00M
Net Cash Per Share $4.09
Equity / Book Value 309.24M
Book Value Per Share 3.46
Working Capital 318.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$151.43 million and capital expenditures -$25,735, giving a free cash flow of -$151.45 million.

Operating Cash Flow -151.43M
Capital Expenditures -25,735
Free Cash Flow -151.45M
FCF Per Share -$1.56
Full Cash Flow Statement

Margins

Gross margin is 96.51%, with operating and profit margins of -1,253.19% and -1,255.76%.

Gross Margin 96.51%
Operating Margin -1,253.19%
Pretax Margin -1,211.71%
Profit Margin -1,255.76%
EBITDA Margin -1,211.37%
EBIT Margin -1,211.71%
FCF Margin -967.41%

Dividends & Yields

NAMS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -448.41%
Shareholder Yield -448.41%
Earnings Yield -10.27%
FCF Yield -7.91%

Analyst Forecast

The average price target for NAMS is $33.25, which is 55.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target $33.25
Price Target Difference 55.08%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 33.03%
EPS Growth Forecast (5Y) -4.92%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date Nov 23, 2022
Split Type n/a
Split Ratio 1:1

Scores

NAMS has an Altman Z-Score of 16.35 and a Piotroski F-Score of 2.

Altman Z-Score 16.35
Piotroski F-Score 2